• Explore /
  • Poster
  • / Phase II study of neoadjuvant IGFBP-2 vaccination with neoadjuvant carboplatin and paclitaxel in advanced ovarian cancer.

Phase II study of neoadjuvant IGFBP-2 vaccination with neoadjuvant carboplatin and paclitaxel in advanced ovarian cancer.

Abstract Poster

Authors

null

William Rayford Gwin III

University of Washington, Seattle, WA

William Rayford Gwin III, Jennifer Childs , Doreen Higgins , Hania Shakalia , John Ben Liao , Mary L. Disis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03029611

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS5613)

DOI

10.1200/JCO.2018.36.15_suppl.TPS5613

Abstract #

TPS5613

Poster Bd #

333b

Abstract Disclosures

Similar Posters

First Author: William R Gwin III

First Author: Yi Jiang

First Author: Bradley Corr

First Author: Helene Blons